ArticleVox sanguinis2011
An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients.
Article in Vox sanguinis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 44 citations in OpenAlex.
- Trial
- The Evolution of Blood Product Use in Trauma Resuscitation: Change Has Come.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2021Article
- Article
- Review
- Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.Clinics in laboratory medicine · 2020Review
- Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions.Blood advances · 2017Article
- Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.Blood transfusion = Trasfusione del sangue · 2015Article
- ABO matching of platelet transfusions - "Start Making Sense". "As we get older, and stop making sense…" - The Talking Heads (1984).Blood transfusion = Trasfusione del sangue · 2015Article
- Platelet transfusion - the new immunology of an old therapy.Frontiers in immunology · 2015Review
- ABO mismatched platelet transfusions in trauma patients.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2014Article
- Platelet transfusion - the art and science of compromise.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2013Article
- Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B.Transfusion · 2013Article
- Detection of Anti-Non-α-Gal Xenoreactive Antibodies in Human Blood Products.XenotransplantationArticle
- Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility.Asian journal of transfusion scienceReview
- Transfusion of ABO non-identical platelets increases the severity of trauma patients at ICU admission.Hematology, transfusion and cell therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 1 institution in 1 country.
Funding
Abstract
backgroundTransfusion of ABO non-identical plasma, platelets and cryoprecipitate is routine practice even though adverse effects can occur. METHODS AND MATERIALS: Our hospital changed transfusion practice in 2005 and adopted a policy of providing ABO-identical blood components to all patients when feasible. We retrospectively compared the transfusion requirements, length of stay and in-hospital mortality in relation to ABO blood group in surgical patients who received platelet transfusions before and after this change to determine whether it resulted in any benefit.
resultsPrior to the change in practice, both group B and AB patients received more ABO non-identical platelet transfusion (P=0·0004), required significantly greater numbers of red cell transfusions (P=0·04) and had 50% longer hospital stays (P=0·039) than group O and A patients. Following the policy change, there was a trend for fewer red cell transfusions (P=0·17) and length of stay in group B and AB patients than group O or A patients. Overall, the mortality rate per red cell transfusion decreased from 15·2 per 1000 to 11·0 per 1000 (P=0·013).
conclusionsThese results, in the context of previous findings, suggest that providing ABO-identical platelets and cryoprecipitate might be associated with reduction in transfusion requirements and improve outcomes in surgical patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.